R&D
Patent
| Technology | Title of Invention | Status | Number |
|---|---|---|---|
| Vaccine (TB Prevention) |
Vaccine composition for tuberculosis containing Rv0351 protein | Registration | 10-1624208 |
| Vaccine composition for tuberculosis containing Rv3131 protein | Registration | 10-1579861 | |
| Vaccine composition for tuberculosis containing MTBK_24820 | Registration | 10-1568736 | |
| Vaccine composition for tuberculosis containing MTBK_20620 | Registration | 10-1672352 | |
| Vaccine composition for tuberculosis containing MTBK_20640 | Registration | 10-1705769 | |
| Vaccine composition for preventing tuberculosis containing a glycosylated Ag85A protein and method for producing the vaccine composition | Prosecution | 10-2019-0010431 | |
| Cell Therapy Platform (Dendritic Cell) | Composition for treating and preventing of tuberculosis comprising dendritic cell and antibiotic agent | Registration | 10-1828044 |
| Composition for boosting of tuberculosis vaccine comprising dendritic cell | Registration | 10-1892598 | |
| Pharmaceutical composition for preventing or treating hypersensitivity immune disease and the method for preparing thereof | Registration | 10-2003958 | |
| Maturation compositions of dendritic cell containing the Rv2299c protein or Rv2299c fused ESAT-6 protein | Registration | 10-1749165 | |
| Tolerorgenic plasmacytoid dendritic cells and the method for preparing thereof) | Registration | 10-1946572 | |
| Pharmaceutical composition for preventing or treating autoimmune disease and the method for preparing thereof) | Registration | 10-1893886 | |
| Peptide Nucleic Acid (PNA) |
Novel PNA and antibacterial composition comprising the same | Registration | 10-1501099 |
| Novel PNA and antibacterial composition comprising the same | Registration | 10-1535874 | |
| STING Agonist | Adjuvant and vaccine composition comprising STING agonist | Registration | 10-1982710 |
| Adjuvant and vaccine composition comprising STING agonist | Registration | 10-2122955 | |
| TB Detection | A multiplex PCR primer set, a composition and a kit comprising the same for diagnosing Mycobacterium tuberculosis and non-tuberculous mycobacteria | Registration | 10-1802417 |
| Biomarker | Biomarker for diagnosing infectious disease by nontuberculous mycobacteria | Prosecution | 10-2019-0151914 |
| Biomarker for predicting the treatment response of inflammation by nontuberculous mycobacteria | Prosecution | 10-2019-0151915 | |
| Biomarker for predicting spontaneous bacteriuim negative after the infection by nontuberculous mycobacteria | Prosecution | 10-2019-0151924 | |
| Biomarker for predicting the prolonged positive result after the infection by nontuberculous mycobacteria | Prosecution | 10-2019-0151926 | |
| Biomarker for differentiating infectious disease by nontuberculous mycobacteria | Prosecution | 10-2019-0151931 | |
| Host directed treatment | Composition for host directed treatment | Prosecution | 10-2019-0141597 |